跳至主要内容
临床试验/PACTR201508001241218
PACTR201508001241218招募中未知

Botulinum Neurotoxin as first line therapy in the management of Childhood esotropia

未提供0 个研究点目标入组 250 人开始时间: 2015年8月17日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Month(s) 至 6 Year(s)(—)
性别
All

入选标准

  • Children between the ages of 6 months to 6 years with essential esotropia.
  • Children with partially accommodative esotropia who require surgery to correct residual angle.
  • Children diagnosed with acquired non accommodative esotropia.
  • Children with concomitant esotropia secondary to neurodevelopmental disorders.

排除标准

  • Any concomitant esotropia corrected fully with spectacle correction.
  • Significant associated vertical misalignment such as dissociative vertical deviation or inferior oblique overaction requiring surgery for these conditions.
  • Strabismus secondary to ocular pathology.
  • incomitant esotropia.
  • Patients refusing to be randomised.

研究者

发起方
未提供

相似试验